Rchr
J-GLOBAL ID:201801004460211054
Update date: Dec. 18, 2024
Mariko Tsukagoshi
ツカゴシ マリコ | Mariko Tsukagoshi
Affiliation and department:
Job title:
Assistant Professor
Research field (2):
Tumor diagnostics and therapeutics
, Digestive surgery
Research keywords (4):
肝胆膵外科
, サルコペニア
, 腹腔鏡手術
, 腫瘍免疫
Research theme for competitive and other funds (8):
- 2023 - 2026 Impact of sarcopenia and creation of novel therapeutic targets by immunotherapeutic resistance mechanisms in hepatocellular carcinoma
- 2022 - 2025 STMN1を標的とした化学療法・温熱療法とのシナジーによる膵癌新規治療法の開発
- 2021 - 2024 Identification of novel immune check point molecules in exhausted CD8+ T cells
- 2021 - 2023 IL-17産生γδ型T細胞を制御する新規癌免疫療法の創生を目指した基礎的研究
- 2020 - 2022 Development of new therapeutic methods targeting cytokine regulators in cancer-related fibroblasts
- 2019 - 2022 Evaluation of the effect of sarcopenia on liver regeneration from the viewpoint between liver and muscle correlation
- 2018 - 2021 New humoral factor facilitates hepato-biliary and pancreatic cancer progression and development of innovative thrapy
- 2018 - 2020 Development of innovative treatment targeting liver cancer associated fibroblast
Show all
Papers (90):
-
Takamichi Igarashi, Norifumi Harimoto, Ryosuke Fukushima, Kei Hagiwara, Kouki Hoshino, Shunsuke Kawai, Norihiro Ishii, Mariko Tsukagoshi, Kenichiro Araki, Ken Shirabe. Significance of the modified global leadership initiative on malnutrition (GLIM) criteria malcondition for patients with biliary tract cancer. Surgery today. 2024
-
Akira Watanabe, Norifumi Harimoto, Kenichiro Araki, Takamichi Igarashi, Mariko Tsukagoshi, Norihiro Ishii, Kei Hagiwara, Katsuhiko Tsunekawa, Masami Murakami, Ken Shirabe. Perioperative pancreaticoduodenectomy management strategy focusing on postoperative early drain colonization. Surgery today. 2024. 54. 9. 1067-1074
-
Ryosuke Fukushima, Norifumi Harimoto, Takayuki Okuyama, Takaomi Seki, Kouki Hoshino, Kei Hagiwara, Shunsuke Kawai, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, et al. New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm. International journal of clinical oncology. 2024. 29. 8. 1182-1190
-
Mariko Tsukagoshi, Kenichiro Araki, Ken Shirabe. Pancreatic cancer and sarcopenia: a narrative review of the current status. International journal of clinical oncology. 2024. 29. 8. 1055-1066
-
Ryosuke Fukushima, Norifumi Harimoto, Takayuki Okuyama, Takaomi Seki, Kouki Hoshino, Kei Hagiwara, Shunsuke Kawai, Norihiro Ishii, Mariko Tsukagoshi, Takamichi Igarashi, et al. Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer. International journal of clinical oncology. 2024. 29. 7. 1002-1011
more...
MISC (216):
-
関 貴臣, 播本 憲史, 新木 健一郎, 久保 憲生, 渡辺 亮, 五十嵐 隆通, 塚越 真梨子, 小林 剛, 柿崎 暁, 伊古田 勇人, et al. 肝細胞癌・混合型肝癌に対して集学的治療を行った1例. 日本臨床外科学会雑誌. 2019. 80. 増刊. 853-853
-
播本 憲史, 石井 範洋, 塚越 真梨子, 五十嵐 隆通, 渡辺 亮, 久保 憲生, 新木 健一郎, 細内 康男, 鈴木 秀樹, 荒川 和久, et al. 膵神経内分泌腫瘍におけるバイオマーカーとしての好中球リンパ球比の意義. 日本癌治療学会学術集会抄録集. 2019. 57回. P27-3
-
播本 憲史, 星野 弘毅, 村主 遼, 萩原 慶, 山中 崇弘, 石井 範洋, 塚越 真梨子, 五十嵐 隆通, 渡辺 亮, 久保 憲生, et al. 膵神経内分泌腫瘍におけるNLR(neutrophil-lymphocyte ratio)の意義に関する検討. 膵臓. 2019. 34. 3. A193-A193
-
播本 憲史, 調 憲, 塚越 真梨子. 【NAFLD/NASH-診断・治療の最新動向-】 サルコペニアとNAFLD/NASH. 日本臨床. 2019. 77. 5. 878-883
-
播本 憲史, 星野 弘毅, 村主 遼, 萩原 慶, 山中 崇弘, 石井 範洋, 塚越 真梨子, 五十嵐 隆通, 田中 寛, 渡辺 亮, et al. 膵神経内分泌腫瘍切除症例におけるNLR(neutrophil-lymphocyte ratio)の意義に関する検討. 日本外科学会定期学術集会抄録集. 2019. 119回. PS-6
more...
Education (2):
- 2013 - 2017 群馬大学大学院医学系研究科 医科学専攻博士課程
- 2002 - 2008 Gunma University
Work history (7):
Committee career (2):
- 2021/09 - 現在 日本消化器外科学会 規約委員会
- 2020/09 - 2024/08 日本消化器外科学会 U-40委員会
Awards (6):
Return to Previous Page